Literature DB >> 19630694

Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects.

Shilpi Pradhan1, Kumar Abhishek, Francis Mah.   

Abstract

BACKGROUND: Epinastine is a topical ophthalmic antihistamine and a mast cell stabilizer indicated for treatment of symptoms associated with allergic conjunctivitis.
OBJECTIVE: The objective of this review is to provide a comprehensive overview of the pharmacology, clinical efficacy, tolerability and safety of epinastine 0.05% ophthalmic solution.
METHODS: Medline literature review from 1950 to 2008.
CONCLUSIONS: Epinastine 0.05% ophthalmic solution was found to be a safe and effective medication for the relief of symptoms of allergic conjunctivitis. Epinastine demonstrates very low CNS and cardiac toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630694     DOI: 10.1517/17425250903117284

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  1 in total

Review 1.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.